| Jourdan M Brown, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 934-4011 | |
| Not Available |
| Full Name | Jourdan M Brown |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679102958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 43763 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Kaiser Health News staff writer Phil Galewitz reports on the Chamber's latest take on the next steps in health reform. "Despite unleashing a new round of TV spots last week that blasts congressional Democrats' health overhaul, the U.S. Chamber of Commerce acknowledged at a media briefing Tuesday that the fight is just about over.
The ongoing COVID-19 pandemic has marched its way to almost all parts of the world, with hundreds of thousands of deaths and over 4.5 million cases as of May 15, 2020. One saving grace has been the apparent sparing of children, though the mortality in older people is quite high.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
July Fourth was not the celebration President Joe Biden had hoped for, as far as protecting more Americans with a coronavirus vaccine.
Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jourdan M Brown, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Jourdan M Brown, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 934-4011 |
News Archive
Kaiser Health News staff writer Phil Galewitz reports on the Chamber's latest take on the next steps in health reform. "Despite unleashing a new round of TV spots last week that blasts congressional Democrats' health overhaul, the U.S. Chamber of Commerce acknowledged at a media briefing Tuesday that the fight is just about over.
The ongoing COVID-19 pandemic has marched its way to almost all parts of the world, with hundreds of thousands of deaths and over 4.5 million cases as of May 15, 2020. One saving grace has been the apparent sparing of children, though the mortality in older people is quite high.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has announced further positive data on the first forty subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma, with an objective response ("OR") observed in 61% of subjects and a mean Progression Free Survival ("PFS") of at least 11.1 months among those subjects achieving an OR.
July Fourth was not the celebration President Joe Biden had hoped for, as far as protecting more Americans with a coronavirus vaccine.
Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.
› Verified 6 days ago
Carlos Aristizabal, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-4011 | |
Ronnie Mathews, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Mark Cromer, Hospitalist Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-9999 | |
Hugh Davidson Reeves, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-9666 | |
Laura Nye, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Kierstin Kennedy, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Patricia Aiken, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 |